Efficacy and tolerability of metallic stent in patients with malignant prostatic obstruction secondary to prostatic cancer
- 25 March 2021
- journal article
- research article
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 13 (3) , 329-334
Abstract
Objective To evaluate the efficacy and tolerability of a self‐expandable covered metallic stent in patients with malignant prostatic obstruction secondary to prostate cancer (PC). Methods We reviewed 22 cases of insertion of self‐expandable covered metallic stents with barbs. Data were collected about PC status. Uroflowmetry variables, residual urine volume, International Prostate Symptom Score (IPSS), quality of life (QOL), and duration from stent insertion to removal were surveyed. These clinical parameters were compared before and after stent insertion. Results The patients with PC showed a mean age of 75.5 ± 6.5 years and mean 5.1 ± 1.9 Charlson comorbidity index. The average flow rate (2.4 ± 1.9 vs 5.9 ± 2.4 mL/s, P = .005), peak flow rate (6.9 ± 6.2 vs 14.1 ± 5.5 mL/s, P = .003), flow time (54.6 ± 29.1 vs 23.6 ± 13.7 s, P = .002), residual urine volume (178.7 ± 195.5 vs 7.0 ± 7.1 mL, P = .004), IPSS (26.2 ± 8.1 vs 8.0 ± 6.5 points, P = .001), and QOL (4.7 ± 1.3 vs 2.4 ± 2.1 points, P = .030) improved between before and after stent insertion, respectively. Pain was the most common complication, but 60% of the patients were managed without any intervention. There were hematuria, urinary retention, urinary frequency, obstruction, and urinary incontinence. However, there was no urinary tract infection due to the stent. The median time to stent removal was 5.7 months. Conclusions The stent was maintained for about 6 months with improved objective and subjective outcomes. The patients with PC, who had a poor comorbidity index and advanced PC status showed a tolerable maintenance period. Self‐expandable covered metallic stents can be used for PC patients with a short life expectancy and unsuitability for general anesthesia.Keywords
This publication has 16 references indexed in Scilit:
- Worse Urinary, Sexual and Bowel Function Cause Emotional Distress and Vice Versa in Men Treated for Prostate CancerJournal of Urology, 2018
- Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching studyJournal of Cancer Research and Clinical Oncology, 2018
- Allium Stents: A Novel Solution for the Management of Upper and Lower Urinary Tract StricturesRambam Maimonides Medical Journal, 2017
- Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?Journal of Endourology, 2016
- Placement of retrievable self-expandable metallic stents with barbs into patients with obstructive prostate cancerEuropean Radiology, 2012
- Stenting of the Lower Gastrointestinal Tract: Current StatusCardioVascular and Interventional Radiology, 2010
- Stenting of the Upper Gastrointestinal Tract: Current StatusCardioVascular and Interventional Radiology, 2010
- Evaluation of Trends in the Cost of Initial Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2008
- Palliative Transurethral Prostate Resection for Bladder Outlet Obstruction in Patients With Locally Advanced Prostate CancerJournal of Urology, 2004
- Urolume Stents: Lessons LearnedJournal of Urology, 2002